These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 23894034

  • 1. In vivo validation and physiologically based biokinetic modeling of the inhibition of SULT-mediated estragole DNA adduct formation in the liver of male Sprague-Dawley rats by the basil flavonoid nevadensin.
    Alhusainy W, Paini A, van den Berg JH, Punt A, Scholz G, Schilter B, van Bladeren PJ, Taylor S, Adams TB, Rietjens IM.
    Mol Nutr Food Res; 2013 Nov; 57(11):1969-78. PubMed ID: 23894034
    [Abstract] [Full Text] [Related]

  • 2. Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect.
    Alhusainy W, Paini A, Punt A, Louisse J, Spenkelink A, Vervoort J, Delatour T, Scholz G, Schilter B, Adams T, van Bladeren PJ, Rietjens IM.
    Toxicol Appl Pharmacol; 2010 Jun 01; 245(2):179-90. PubMed ID: 20226806
    [Abstract] [Full Text] [Related]

  • 3. Matrix-derived combination effect and risk assessment for estragole from basil-containing plant food supplements (PFS).
    van den Berg SJ, Klaus V, Alhusainy W, Rietjens IM.
    Food Chem Toxicol; 2013 Dec 01; 62():32-40. PubMed ID: 23959103
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A physiologically based biodynamic (PBBD) model for estragole DNA binding in rat liver based on in vitro kinetic data and estragole DNA adduct formation in primary hepatocytes.
    Paini A, Punt A, Viton F, Scholz G, Delatour T, Marin-Kuan M, Schilter B, van Bladeren PJ, Rietjens IM.
    Toxicol Appl Pharmacol; 2010 May 15; 245(1):57-66. PubMed ID: 20144636
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunochemical identification of hepatic protein adducts derived from estragole.
    Wakazono H, Gardner I, Eliasson E, Coughtrie MW, Kenna JG, Caldwell J.
    Chem Res Toxicol; 1998 Aug 15; 11(8):863-72. PubMed ID: 9705747
    [Abstract] [Full Text] [Related]

  • 17. Physiologically based biokinetic (PBBK) model for safrole bioactivation and detoxification in rats.
    Martati E, Boersma MG, Spenkelink A, Khadka DB, Punt A, Vervoort J, van Bladeren PJ, Rietjens IM.
    Chem Res Toxicol; 2011 Jun 20; 24(6):818-34. PubMed ID: 21446753
    [Abstract] [Full Text] [Related]

  • 18. Progenitor-derived hepatocyte-like (B-13/H) cells metabolise 1'-hydroxyestragole to a genotoxic species via a SULT2B1-dependent mechanism.
    Probert PM, Palmer JM, Alhusainy W, Amer AO, Rietjens IM, White SA, Jones DE, Wright MC.
    Toxicol Lett; 2016 Jan 22; 243():98-110. PubMed ID: 26739637
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.